Long-acting combination of cabotegravir plus rilpivirine: a picture of potential eligible HIV-positive individuals from the Italian ARCA cohort

被引：0
|
作者：
Cervo, A. [1 ]
Russo, A. [2 ]
Di Carlo, D. [3 ]
De Vito, A. [4 ]
Fabeni, L. [5 ]
D'Anna, S. [6 ]
Duca, L. [6 ]
Colpani, A.
Fois, M.
Zauli, B.
Mancarella, G. [7 ]
Carraro, A. [7 ]
Bezenchek, A. [8 ]
Cozzi-Lepri, A. [9 ]
Santoro, M. [6 ]
机构：
[1] Univ Hosp Modena, Infect Dis Clin, Modena, Italy
[2] Univ Campania Luigi Vanvitelli, Dept Mental Hlth, Infect Dis Unit, Naples, Italy
[3] Univ Milan, Dept Biomed Clin Sci L Sacco, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, Milan, Italy
[4] Univ Sassari, Dept Med Surg & Expt Sci, Unit Infect Dis, Sassari, Italy
[5] L Spallanzani Natl Inst Infect Dis, Rome, Italy
[6] Tor Vergata Univ Rome, Rome, Italy
[7] Sapienza Univ Rome Polo Pontino, Unit Infect Dis, Latina, Italy
[8] InformaPRO SRL, EuResist Network GEIE, Rome, Italy
[9] Inst Global Hlth, Ctr Clin Res Epidemiol Modelling & Evaluat, London, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P096
引用
收藏
页码：95 / 97
页数：3
相关论文
共 50 条
  • [1] Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort
    Cervo, Adriana
    Russo, Antonio
    Di Carlo, Domenico
    De Vito, Andrea
    Fabeni, Lavinia
    D'Anna, Stefano
    Duca, Leonardo
    Colpani, Agnese
    Fois, Marco
    Zauli, Beatrice
    Mancarella, Giulia
    Carraro, Anna
    Bezenchek, Antonia
    Cozzi-Lepri, Alessandro
    Santoro, Maria Mercedes
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 34 : 141 - 144
  • [2] Cabotegravir plus Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Sension, Michael G.
    Brunet, Laurence
    Hsu, Ricky K.
    Fusco, Jennifer S.
    Cochran, Quateka
    Uranaka, Christine
    Sridhar, Gayathri
    Vannappagari, Vani
    Van Wyk, Jean
    Mccurdy, Lewis
    Wohlfeiler, Michael B.
    Fusco, Gregory P.
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (12) : 2709 - 2724
  • [3] Acceptability of Long-Acting Cabotegravir plus Rilpivirine in a Large, Urban, Ambulatory HIV Clinic
    Luc, Casey Morgan
    Max, Blake
    Perez, Sarah
    Herrera, Kara
    Huhn, Gregory
    Dworkin, Mark S.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2024, 97 (04) : 409 - 415
  • [4] Long-acting cabotegravir plus rilpivirine for HIV treatment: FLAIR week 96 results
    Orkin, C.
    Oka, S.
    Philibert, P.
    Brinson, C.
    Bassa, A. C.
    Gusev, D.
    Degen, O.
    Gonzalez Garcia, J.
    D'Amico, R.
    Dorey, D.
    Griffith, S.
    Margolis, D. A.
    St Clair, M.
    Williams, P.
    Spreen, W. R.
    HIV MEDICINE, 2020, 21 : 14 - 14
  • [5] Uptake and discontinuation of the long-acting duo in the Swiss HIV Cohort Study: Preliminary analysis on cabotegravir plus rilpivirine
    Ramirez, J. J. Duran
    Kusejko, K.
    Metzner, K. J.
    Huber, M.
    Martin, Y.
    Stockle, M.
    Calmy, A.
    Decosterd, L. A.
    Cavassini, M.
    Bernasconi, E.
    Schmid, P.
    Gunthard, H. F.
    Braun, D. L.
    HIV MEDICINE, 2023, 24 : 79 - 81
  • [6] COST-EFFECTIVENESS OF LONG-ACTING CABOTEGRAVIR PLUS LONG-ACTING RILPIVIRINE FOR THE TREATMENT OF HIV-1 IN TAIWAN
    Wen, Y. C.
    Ou, H. T.
    Tien, K.
    Harrison, C.
    Omonmhenle, D.
    Turner, M.
    Anderson, S. J.
    Jacob, I
    VALUE IN HEALTH, 2023, 26 (06) : S145 - S145
  • [7] An evaluation of long-acting cabotegravir plus rilpivirine for the treatment of virologically suppressed adults living with HIV
    Qazzaz, Hamdi
    Parganas, Christopher
    Cory, Theodore James
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (13) : 1485 - 1495
  • [8] Long-acting cabotegravir and rilpivirine in HIV individuals with a BMI over 30: a real-world study (RELATIVITY cohort)
    Troya, Jesus
    Morano, Luis
    Ignacio Bernardino, Jose
    Buzon Martin, Luis
    Pedrero Tome, Roberto
    Galindo Puerto, Maria Jose
    Torralba, Miguel
    Cabello Clotet, Noemi
    Garcia Lopez, Maria
    Lope, Silvia
    de Zarraga Fernandez, Miguel Alberto
    Cabello, Alfonso
    Aguilera Garcia, Maria
    Cecilio, Alvaro
    Diaz de Santiago, Alberto
    Garcinuno Jimenez, Maria Angeles
    Bernal, Enrique
    Lopez Caballero, Maria Teresa
    Calderon Hernaiz, Ruth
    Vivancos Gallego, Maria Jesus
    Omiste Sanvicente, Teresa
    Ferreira Pasos, Eva
    Losa Garcia, Juan Emilio
    Soler Gonzalez, Josefa Francisca
    Antonia Sepulveda, Maria
    Garcia Navarro, Maria del Mar
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 92 - 93
  • [9] Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Michael G. Sension
    Laurence Brunet
    Ricky K. Hsu
    Jennifer S. Fusco
    Quateka Cochran
    Christine Uranaka
    Gayathri Sridhar
    Vani Vannappagari
    Jean Van Wyk
    Lewis McCurdy
    Michael B. Wohlfeiler
    Gregory P. Fusco
    Infectious Diseases and Therapy, 2023, 12 : 2807 - 2817
  • [10] The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment
    Alberton, Francesca
    Nozza, Silvia
    Raccagni, Angelo Roberto
    Galli, Laura
    Spagnuolo, Vincenzo
    Bossolasco, Simona
    Cernuschi, Massimo
    Canetti, Diana
    Hasson, Hamid
    Castagna, Antonella
    Gianotti, Nicola
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
12345